AI-generated summary
The authors report a randomised, double-blind trial of bright light therapy versus dim red light placebo in 67 pregnant women with depression in the Netherlands. Depressive symptoms improved in both groups, with no statistically significant difference between them. The authors state that it remains unclear whether these responses reflect true treatment effects or placebo effects.
- Participants
- 67
- Who or what was studied
- Pregnant women aged 12 to 32 weeks gestation with a DSM-5 diagnosis of depressive disorder, recruited in primary and secondary care in The Netherlands
- Limits stated in the abstract
- The abstract does not state the size of the placebo effect or give confidence intervals, and the authors say more research is needed to determine whether the responses were true treatment effects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Objectives
Approximately 11%-13% of pregnant women suffer from depression. Bright light therapy (BLT) is a promising treatment, combining direct availability, sufficient efficacy, low costs and high safety for both mother and child. Here, we examined the effects of BLT on depression during pregnancy.
Design
Randomised, double-blind controlled trial.
Setting
Primary and secondary care in The Netherlands, from November 2016 to March 2019.
Participants
67 pregnant women (12-32 weeks gestational age) with a DSM-5 diagnosis of depressive disorder (Diagnostic and Statistical Manual of Mental Disorders).
Interventions
Participants were randomly allocated to treatment with either BLT (9000 lux, 5000 K) or dim red light therapy (DRLT, 100 lux, 2700 K), which is considered placebo. For 6 weeks, both groups were treated daily at home for 30 min on awakening. Follow-up took place weekly during the intervention, after 6 weeks of therapy, 3 and 10 weeks after treatment and 2 months postpartum. PRIMARY AND SECONDARY
Outcome Measures
Depressive symptoms were measured primarily with the Structured Interview Guide for the Hamilton Depression Scale-Seasonal Affective Disorder. Secondary measures were the Hamilton Rating Scale for Depression and the Edinburgh Postnatal Depression Scale. Changes in rating scale scores of these questionnaires over time were analysed using generalised linear mixed models.
Results
Median depression scores decreased by 40.6%-53.1% in the BLT group and by 50.9%-66.7% in the DRLT group. We found no statistically significant difference in symptom change scores between BLT and DRLT. Sensitivity and post-hoc analyses did not change our findings.
Conclusions
Depressive symptoms of pregnant women with depression improved in both treatment arms. More research is necessary to determine whether these responses represent true treatment effects, non-specific treatment responses, placebo effects or a combination hereof.
Trial Registration Number
NTR5476.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy, Lux, Trial registration, Red light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.